Centre for Blood Research (@cbr-uoy.bsky.social)

New study from CBR Leaders and BRC collaborators on COVID-19 mortality in patients with blood cancers vs the general population (UK cohort, ~4M people) pubmed.ncbi.nlm.nih.gov/41220109/ #COVID19 #Haematology

loading . . .

COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research Network - PubMed When the World Health Organization (WHO) declared the global COVID-19 pandemic, it was recognised that patients with haematological cancers would be more susceptible to severe disease. Set within a UK population of ~4 million (https://hmrn.org/), all patients diagnosed with haematological neoplasms … https://pubmed.ncbi.nlm.nih.gov/41220109/